 For millions of diabetic patients worldwide, the reality of constantly having needles pricked into the body for glucose monitoring can be a never-ending nightmare. With over 460 million people currently suffering from diabetes and the number of pre-diabetes cases at almost 3 times this number, diabetes is an urgent global health crisis that companies like Nemaura Medical, Inc. NASDAQ: NMRD , are working around the clock to manage and reverse. 